Takeda Pharmaceutical Company Limited (TAK)
Data as of September 4, 2026 · Drug Manufacturers - Specialty & Generic
Stockbruh grade: Mixed 2/5 metrics rated Sunny
What does Takeda Pharmaceutical Company Limited do?
🏢 Takeda Pharmaceutical specializes in developing, making, and selling awesome meds 🧪🌟 from Japan to the rest of the world 🌎! They're into gastroenterology, rare diseases, oncology, and more. Using cool brands like Entyvio, Dexilant, and Vyvanse, Takeda helps people feel better. Based in Tokyo 🗼, they've been at it since 1781! 🎉✨.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛈️ Weak | Revenue & earnings trend |
| Earnings | ⛈️ Weak | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $18.71 | Market Cap | — |
| Exchange | New York Stock Exchange | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
🏢 Takeda Pharmaceutical specializes in developing, making, and selling awesome meds 🧪🌟 from Japan to the rest of the world 🌎! They're into gastroenterology, rare diseases, oncology, and more. Using cool brands like Entyvio, Dexilant, and Vyvanse, Takeda helps people feel better. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth has been challenging recently. Revenue or earnings are showing weak trends. Sign up free to see the full picture including forward projections.
What's ahead?
Recent earnings have disappointed — missing expectations or reporting losses. Sign up free to see the full earnings analysis and what's driving the weakness.